Angio-Seal

Angio-Seal™

A mechanical and biochemical seal used to close arterial puncture wounds created during diagnostic and therapeutic catheterisation procedures (e.g., cardiac angiographies and percutaneous transluminal coronary angioplasty; peripheral angiography; coronary and peripheral stent placement).

Angio-Seal™

Interventional cardiology A mechanical and biochemical seal used to close arterial puncture wounds created during diagnostic and therapeutic catheterization procedures–eg cardiac angiographies and percutaneous transluminal coronary angioplasty–PTCA, peripheral angiography, coronary and peripheral stent placement. See Interventional cardiology.
References in periodicals archive ?
In addition, the remnants of the Angio-Seal closure device (string and collagen plug) were removed from the distal popliteal artery.
Jude Medical which resolves all disputes relating to the Angio-Seal vascular closure devices licenses and agreed to extend collagen supply agreement through 2017.
The Caguas site will continue to manufacture mechanical heart valves and Angio-Seal vascular closure devices, and also is expected to add new product lines in the future, said Daniel J.
The Duett device relies on its own six issued and five pending United States patents, dating back to 1993, and is vastly different from the Angio-Seal product.
Jude Medical which resolves all disputes between the two companies relating to the Angio-Seal vascular closure device licenses, as well as other related claims.
Registry results confirm the excellent sealing performance of Angio-Seal vascular closure devices in interventional radiology procedures
Clinical Data Validate Angio-Seal Vascular Closure Systems' Successful 15-Year History with More Than 15 Million Angio-Seal Devices Distributed Globally
Jude Medical to enter into non-binding mediation in an attempt to resolve disputes over royalty payments to Kensey Nash relating to the Angio-Seal vascular closure device, as well as other related claims.
Jude Medical presents the eighth generation of the successful Angio-Seal product family with the most advanced design yet - the Angio-Seal[TM] Evolution[TM].
The single-blinded, randomized, single-center, controlled trial compared the discomfort associated with the Mynx 5F Vascular Closure Device versus the Angio-Seal Evolution Device.
The Angio-Seal Evolution platform features an entirely new delivery system that significantly reduces the variability that can occur as physicians deploy and secure the Angio-Seal closure system.
Royalties under the Angio-Seal license agreement between Kensey Nash and St.